<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Support Care Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Support Care Cancer</journal-id><journal-title-group><journal-title>Supportive Care in Cancer</journal-title></journal-title-group><issn pub-type="ppub">0941-4355</issn><issn pub-type="epub">1433-7339</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39537939</article-id><article-id pub-id-type="pmc">PMC11561107</article-id>
<article-id pub-id-type="publisher-id">9004</article-id><article-id pub-id-type="doi">10.1007/s00520-024-09004-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Effect of therapeutic exercise on peak oxygen consumption in oncological population: a systematic review with meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8604-5426</contrib-id><name><surname>del-Rosal-Jurado</surname><given-names>Alicia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3993-5092</contrib-id><name><surname>Gonz&#x000e1;lez-S&#x000e1;nchez</surname><given-names>Manuel</given-names></name><address><email>mgsa23@uma.es</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8880-4315</contrib-id><name><surname>Cuesta-Vargas</surname><given-names>Antonio Ignacio</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/036b2ww28</institution-id><institution-id institution-id-type="GRID">grid.10215.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 7828</institution-id><institution>Department of Physiotherapy, Institute of Biomedicine of M&#x000e1;laga (IBIMA), Faculty of Health Sciences, </institution><institution>University of M&#x000e1;laga, </institution></institution-wrap>29071 M&#x000e1;laga, Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03pnv4752</institution-id><institution-id institution-id-type="GRID">grid.1024.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 8915 0953</institution-id><institution>School of Clinical Sciences of the Faculty of Health, </institution><institution>Queensland University of Technology, </institution></institution-wrap>Brisbane, QLD 4059 Australia </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>32</volume><issue>12</issue><elocation-id>786</elocation-id><history><date date-type="received"><day>19</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>8</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Introduction</title><p id="Par1">Cancer is amongst the leading causes of death worldwide. A total of 19.3 million new cases were diagnosed in 2020. Cardiovascular impairment is the second leading cause of death in patients undergoing cancer treatment. By measuring the maximum rate of oxygen consumption (VO<sub>2</sub>max) in cancer patients, it is possible to estimate their cardiorespiratory health. This study aims to show how participants&#x02019; VO<sub>2</sub>max increases with a therapeutic physical exercise programme.</p></sec><sec><title>Methods</title><p id="Par2">Four databases were used for the literature search. Twenty-eight studies were analysed using the inclusion and exclusion criteria. The quality of these studies was analysed with the PEDRO scale. The structural characteristics of the articles and the study variable (VO<sub>2</sub>max) were studied.</p></sec><sec><title>Results</title><p id="Par3">The VO<sub>2</sub>max of the 2558 patients studied presents some variations by gender, intervention and moment of measurement. For male-associated cancer, the increased VO<sub>2</sub>max ranged between 1.5 and 4.2% after the intervention. The increase in the maximum VO<sub>2</sub>max in female-associated cancer was between 0.3 and 53%. Different types of cancer for both genders presented an oscillation between 0.5 and 3.47%.</p></sec><sec><title>Conclusions</title><p id="Par4">Therapeutic physical exercise is an efficient intervention to improve the VO<sub>2</sub>max in oncology patients. The results show that a therapeutic physical exercise intervention lasting 12 weeks, 3 days per week with a moderate-vigorous intensity, increases the VO<sub>2</sub>max in oncology patients.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cancer</kwd><kwd>Neoplasms</kwd><kwd>Exercise</kwd><kwd>Respiratory function tests</kwd><kwd>Cardiorespiratory fitness</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universidad de M&#x000e1;laga</institution></funding-source></award-group><open-access><p>Funding for open access publishing: Universidad de M&#x000e1;laga/CBUA.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Cancer is amongst the leading causes of death worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. A total of 19.3 million new cases were diagnosed in 2020 [<xref ref-type="bibr" rid="CR1">1</xref>]. Estimates show there may be 30.2 million new cases of cancer by 2040 [<xref ref-type="bibr" rid="CR1">1</xref>]. Advances in diagnostics and treatment techniques are increasing the number of long-term cancer survivors [<xref ref-type="bibr" rid="CR2">2</xref>]. Differentiation by sex has caused the level of specificity in the diagnosis and treatment of cancer to increase in recent years. In this sense, there are cancers that, due to the specific anatomy of women, are identified as &#x0201c;female cancers&#x0201d; [<xref ref-type="bibr" rid="CR3">3</xref>] and, similarly, due to the specific anatomy of men, &#x0201c;male cancers&#x0201d; [<xref ref-type="bibr" rid="CR4">4</xref>] are also identified. Cancer-related effects can be diminished by therapeutic physical exercise (TPE). High-level physical activity decreases the likelihood of cancer by 27% [<xref ref-type="bibr" rid="CR5">5</xref>]. Regular physical activity reduces the risk of developing colon cancer, breast cancer and endometrial cancer [<xref ref-type="bibr" rid="CR6">6</xref>]. TPE is most effective when supervised, in person or online, by a health professional [<xref ref-type="bibr" rid="CR7">7</xref>]. Cardiorespiratory function is a declining adverse effect of cancer [<xref ref-type="bibr" rid="CR8">8</xref>]. Cardiovascular impairment is the second leading cause of death in patients undergoing cancer treatment [<xref ref-type="bibr" rid="CR9">9</xref>]. Cardiorespiratory function is an important predictor factor of health and mortality [<xref ref-type="bibr" rid="CR10">10</xref>]. By measuring maximum rate of oxygen consumption (VO<sub>2</sub>max) in cancer patients, it is possible to estimate their cardiorespiratory health [<xref ref-type="bibr" rid="CR2">2</xref>]. Performance of TPE by oncology patients results in changes in vagal tone, leading to an increase in cardiorespiratory fitness and VO2max [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par6">As indicated above, there are studies demonstrating the benefits of TPE on cardiorespiratory fitness. There are currently no systematic reviews on the most common tumours and types of training used to increase the VO2max of participants.</p><p id="Par7">This study aims to show how participants&#x02019; VO2max increases with a TPE programme.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par8">This systematic review was carried out in agreement with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement and was registered in PROSPERO with reference number CRD42018103258.</p><sec id="Sec3"><title>Search strategy</title><p id="Par9">The literature research was performed through the PubMed, Web of Science, PEDro and CINAHL databases. The following keywords were used: neoplasm, exercise and VO2max. Keywords were combined using the Boolean operators &#x0201c;AND&#x0201d; and &#x0201c;OR&#x0201d;.</p></sec><sec id="Sec4"><title>Study selection</title><p id="Par10">The titles were initially read, and researchers later read the abstract and full documents. All duplicates and those that failed to meet the inclusion criteria were deleted.</p><p id="Par11">The inclusion criteria were randomised control trial, control trial, human studies and language: English, Spanish, French and/or Portuguese.</p><p id="Par12">All studies without oncology patients, TPE intervention and papers without changes in VO2max were excluded.</p><p id="Par13">Two researchers with more than 10 years of experience in this area performed a literature search and study selection.</p></sec><sec id="Sec5"><title>Study of variables</title><p id="Par14">The structural characteristics of the selected articles were studied, along with the other principal variables.</p><p id="Par15">The articles&#x02019; structural characteristics can be found in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Tumour type, gender and age of participants were all studied. Types of training are also shown, as well as some important factors in prescribing a TPE programme: exercise type, session time, duration and supervision.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>PEDro scale</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><italic>Type of study</italic></th><th align="left"><italic>Randomisation</italic></th><th align="left"><italic>Concealed allocation</italic></th><th align="left"><italic>Groups similar baseline</italic></th><th align="left"><italic>Blinding of subjects</italic></th><th align="left"><italic>Blinding of therapist</italic></th><th align="left"><italic>Blinding of assessors</italic></th><th align="left"><italic>85% n</italic></th><th align="left"><italic>Intention to treat</italic></th><th align="left"><italic>Between-group</italic></th><th align="left"><italic>A point measure</italic></th><th align="left"><italic>Score PEDro</italic></th></tr></thead><tbody><tr><td align="left"><italic>Alizadeh </italic>[<xref ref-type="bibr" rid="CR39">39</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>10</bold></td></tr><tr><td align="left"><italic>Bhatia </italic>[<xref ref-type="bibr" rid="CR31">31</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>6</bold></td></tr><tr><td align="left"><italic>Casla </italic>[<xref ref-type="bibr" rid="CR27">27</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>7</bold></td></tr><tr><td align="left"><italic>Courneya </italic>[<xref ref-type="bibr" rid="CR37">37</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>6</bold></td></tr><tr><td align="left"><italic>de Paulo </italic>[<xref ref-type="bibr" rid="CR20">20</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>5</bold></td></tr><tr><td align="left"><italic>Dieli-Conwright </italic>[<xref ref-type="bibr" rid="CR28">28</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>7</bold></td></tr><tr><td align="left"><italic>Dieli-Conwright </italic>[<xref ref-type="bibr" rid="CR26">26</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>8</bold></td></tr><tr><td align="left"><italic>Duggan </italic>[<xref ref-type="bibr" rid="CR30">30</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>7</bold></td></tr><tr><td align="left"><italic>Edvardsen </italic>[<xref ref-type="bibr" rid="CR35">35</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>8</bold></td></tr><tr><td align="left"><italic>Grabenbauer </italic>[<xref ref-type="bibr" rid="CR36">36</xref>]</td><td align="left">CT</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>4</bold></td></tr><tr><td align="left"><italic>Grote </italic>[<xref ref-type="bibr" rid="CR9">9</xref>]</td><td align="left">CT</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>4</bold></td></tr><tr><td align="left"><italic>Hannam Arem </italic>[<xref ref-type="bibr" rid="CR29">29</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>8</bold></td></tr><tr><td align="left"><italic>Hvid </italic>[<xref ref-type="bibr" rid="CR12">12</xref>]</td><td align="left">CT</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>6</bold></td></tr><tr><td align="left"><italic>Lahart </italic>[<xref ref-type="bibr" rid="CR40">40</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>8</bold></td></tr><tr><td align="left"><italic>Lee </italic>[<xref ref-type="bibr" rid="CR18">18</xref>]</td><td align="left">RCT (pilot)</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>8</bold></td></tr><tr><td align="left"><italic>Neill </italic>[<xref ref-type="bibr" rid="CR10">10</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>10</bold></td></tr><tr><td align="left"><italic>May </italic>[<xref ref-type="bibr" rid="CR32">32</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>7</bold></td></tr><tr><td align="left"><italic>Mcneil </italic>[<xref ref-type="bibr" rid="CR22">22</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>8</bold></td></tr><tr><td align="left"><italic>Mehnert </italic>[<xref ref-type="bibr" rid="CR21">21</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>10</bold></td></tr><tr><td align="left"><italic>Quist </italic>[<xref ref-type="bibr" rid="CR33">33</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>4</bold></td></tr><tr><td align="left"><italic>Scott </italic>[<xref ref-type="bibr" rid="CR34">34</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>10</bold></td></tr><tr><td align="left"><italic>Adams </italic>[<xref ref-type="bibr" rid="CR13">13</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>7</bold></td></tr><tr><td align="left"><italic>Tosti </italic>[<xref ref-type="bibr" rid="CR19">19</xref>]</td><td align="left">CT</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>5</bold></td></tr><tr><td align="left"><italic>Uth </italic>[<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>9</bold></td></tr><tr><td align="left"><italic>Wall </italic>[<xref ref-type="bibr" rid="CR15">15</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>5</bold></td></tr><tr><td align="left"><italic>Yee </italic>[<xref ref-type="bibr" rid="CR41">41</xref>]</td><td align="left">RCT (pilot)</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>8</bold></td></tr><tr><td align="left"><italic>Zhijun </italic>[<xref ref-type="bibr" rid="CR42">42</xref>]</td><td align="left">RCT</td><td align="left">X</td><td align="left">-</td><td align="left">X</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left">X</td><td align="left"><bold>6</bold></td></tr></tbody></table><table-wrap-foot><p>Abreviattions : <italic>RCT</italic> Randomiced control trial, <italic>CT</italic> Control trial</p></table-wrap-foot></table-wrap></p><p id="Par16">The principal variable is subjects&#x02019; VO2max. The changes after intervention with a TPE programme in oncology patients were highlighted.</p><p id="Par17">PEDro scale was used to assess study methodology.</p><p id="Par18">This scale consists of 10 points (selection criteria; randomisation of selection: hidden allocation; initial comparability between groups; all blinded subjects; all blinded therapists; all blinded evaluators; adequacy of follow-up; conduct of the analysis with treatment intent; comparison of results between groups; the existence of point and variability measures) that may be dichotomous Yes and No response, granted based on compliance or non-compliance with the requirements of the particular point.</p><p id="Par19">Those studies with scores over or similar to 6 points were considered high quality, and those studies with scores below 6 points were considered low quality.</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par20">To determine the overall OR of the selected studies, the Meta-DiSc software was used. Cochran&#x02019;s Q test was used to evaluate statistical heterogeneity and the forest plot was developed with the same software. The heterogeneity of the studies was then calculated. To calculate heterogeneity, the I2 statistic was calculated. The following scale was used to stratify the different heterogeneity values [<xref ref-type="bibr" rid="CR11">11</xref>]: large heterogeneity I2&#x02009;&#x0003e;&#x02009;50%; moderate heterogeneity I225&#x02013;50%; low heterogeneity: I2&#x02009;&#x0003c;&#x02009;25%; and null heterogeneity I2&#x02009;=&#x02009;0. The level of significance was <italic>p</italic>&#x02009;&#x02264;&#x02009;0.05.</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par21">After searching the literature in principal databases using the keywords, a total of 239 documents were obtained. Fifteen studies were excluded due to duplication, and the 224 remaining documents were subject to inclusion criteria. After applying inclusion criteria and reading titles and abstracts, 208 documents were later eliminated.</p><p id="Par22">Finally, those documents with a different language to the inclusion criteria were excluded. Papers with low internal validity were also excluded. The present review analysed a total of 28 articles. For more details of the search results, see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Flowchart of search results and filtering of the documents selected</p></caption><graphic xlink:href="520_2024_9004_Fig1_HTML" id="MO1"/></fig></p><p id="Par23">The articles&#x02019; structural characteristics are shown in Tables <xref rid="Tab2" ref-type="table">2</xref>, <xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>. These tables show the fundamental factors to prescribe a TPE programme. A total of 2558 patients aged between 18 and 80 were studied in this review. All documents contemplated primary tumour and/or secondary tumour. The most repeated type of training was combined training. The frequency ranged between 2 and 7 days per week. Session time ranged from 30 to 90 min. Accumulated exercise time of the week oscillated between 70 and 220 min per week. The programme&#x02019;s duration ranged between 25 days and 48 weeks. Twenty-two articles of the total 28 selected offered a TPE programme supervised by a health professional.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Structural characteristics of the selected articles. &#x0201c;Cancer men&#x0201d;</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">TYPE OF STUDY</th><th align="left">TYPE OF CANCER</th><th align="left">PATIENTS</th><th align="left">AGE</th><th align="left">TYPE TRAINING</th><th align="left">TIME/WEEK</th><th align="left">DURATION OF SESSION<break/>FREQUENCY</th><th align="left">DURATION OF THE PROGRAM</th><th align="left">SUPERVISED EXERCISE TIME</th></tr></thead><tbody><tr><td align="left">HVID [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td align="left">RCT</td><td align="left">Prostate</td><td align="left">21</td><td align="left">67.8 (6.4)</td><td align="left">Aerobic training</td><td align="left">105 min. /week</td><td align="left"><p>35 min</p><p>3 d/week</p></td><td align="left">12 weeks</td><td align="left">12 weeks</td></tr><tr><td align="left">ADAMS [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td align="left">RCT</td><td align="left">Testicular</td><td align="left">63</td><td align="left">18&#x02013;80</td><td align="left">High intensity interval training</td><td align="left">105/week</td><td align="left"><p>3 d/week</p><p>35 min</p></td><td align="left">12 weeks</td><td align="left">12 weeks</td></tr><tr><td align="left">UTH [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left">RCT</td><td align="left">Prostate cancer</td><td align="left">57</td><td align="left">43&#x02013;74</td><td align="left">Football</td><td align="left">180/week</td><td align="left"><p>3 d/week</p><p>60 min</p></td><td align="left">12 weeks</td><td align="left">12 weeks</td></tr><tr><td align="left">WALL [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td align="left">RCT</td><td align="left">Prostate cancer</td><td align="left">265</td><td align="left">69.1</td><td align="left">Combined training</td><td align="left">270 min /week</td><td align="left"><p>2 d/week</p><p>60 min</p></td><td align="left">24 weeks</td><td align="left">24 weeks</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic>RCT</italic> randomised controlled trial</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Structural characteristics of the selected articles. &#x0201c;Cancer women&#x0201d;</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">TYPE OF STUDY</th><th align="left">TYPE OF CANCER</th><th align="left">PATIENTS</th><th align="left">AGE</th><th align="left">TYPE TRAINING</th><th align="left">TIME/WEEK</th><th align="left">DURATION OF SESSION<break/>FREQUENCY</th><th align="left">DURATION OF THE PROGRAM</th><th align="left">SUPERVISED EXERCISE TIME</th></tr></thead><tbody><tr><td align="left"><bold>ALIZADEH </bold>[<xref ref-type="bibr" rid="CR39">39</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">456</td><td align="left"><p>48.42 (7.54)</p><p>Mean (SD)</p></td><td align="left">Combined training</td><td align="left">114 min/week</td><td align="left"><p>3 d/week</p><p>38 min</p></td><td align="left">12 weeks</td><td align="left">12 weeks</td></tr><tr><td align="left"><bold>CASLA </bold>[<xref ref-type="bibr" rid="CR27">27</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">235</td><td align="left">18&#x02013;70</td><td align="left">Combined training</td><td align="left">-</td><td align="left">2 d/week</td><td align="left">12 weeks</td><td align="left">12 weeks</td></tr><tr><td align="left"><bold>DE PAULO </bold>[<xref ref-type="bibr" rid="CR20">20</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">313</td><td align="left"><p>63.6 (7.2)</p><p>Mean (SD)</p></td><td align="left">Combined training</td><td align="left">210&#x02013;270 min /week</td><td align="left"><p>3 d/week</p><p>70&#x02013;90 min</p></td><td align="left">36 weeks</td><td align="left">36 weeks</td></tr><tr><td align="left"><bold>DIELI-CONWRIGHT </bold>[<xref ref-type="bibr" rid="CR28">28</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">100</td><td align="left"><p>53.5 (10.4)</p><p>Mean (SD)</p></td><td align="left">Combined training</td><td align="left">-</td><td align="left">3 d/week</td><td align="left">16 weeks</td><td align="left">16 weeks</td></tr><tr><td align="left"><bold>DIELI-CONWRIGHT </bold>[<xref ref-type="bibr" rid="CR26">26</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">418</td><td align="left">-</td><td align="left">Combined training</td><td align="left">150&#x02013;240 min/week</td><td align="left"><p>50&#x02013;80 min</p><p>3 d/week</p></td><td align="left"><p>16 weeks</p><p>12 weeks tracking</p></td><td align="left">16 weeks</td></tr><tr><td align="left"><bold>DUGGAN </bold>[<xref ref-type="bibr" rid="CR30">30</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">173</td><td align="left">50&#x02013;75</td><td align="left">Aerobic training</td><td align="left">225 min/week</td><td align="left"><p>45 min</p><p>5 d/week</p></td><td align="left">48 weeks</td><td align="left"/></tr><tr><td align="left"><bold>HANNAM A</bold>rem [<xref ref-type="bibr" rid="CR29">29</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">121</td><td align="left">Postmenopausal women</td><td align="left">Combined training</td><td align="left"/><td align="left">2 d/week</td><td align="left">48 weeks</td><td align="left">48 weeks</td></tr><tr><td align="left"><bold>LAHART </bold>[<xref ref-type="bibr" rid="CR40">40</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">150</td><td align="left">18&#x02013;72</td><td align="left">Aerobic training</td><td align="left">90&#x02013;210 min/week</td><td align="left"><p>3&#x02013;7 d/week</p><p>30 min</p></td><td align="left">24 weeks</td><td align="left">12 weeks</td></tr><tr><td align="left"><bold>LEE </bold>[<xref ref-type="bibr" rid="CR18">18</xref>]</td><td align="left">RCT (pilot)</td><td align="left">Breast cancer</td><td align="left">58</td><td align="left"><p>46.9 (9.8)</p><p>Mean (SD)</p></td><td align="left">High intensity interval training</td><td align="left"/><td align="left"><p>3 d/week</p><p>30 min</p></td><td align="left">8 weeks</td><td align="left">8 weeks</td></tr><tr><td align="left"><bold>MCNEIL </bold>[<xref ref-type="bibr" rid="CR22">22</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">109</td><td align="left">18</td><td align="left">Aerobic training</td><td align="left"/><td align="left">150&#x02013;300 min/week</td><td align="left">24 weeks</td><td align="left"/></tr><tr><td align="left"><bold>MEHNERT </bold>[<xref ref-type="bibr" rid="CR21">21</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">156</td><td align="left">18&#x02013;54</td><td align="left">Combined training</td><td align="left"/><td align="left">2 d/week</td><td align="left">10 weeks</td><td align="left"/></tr><tr><td align="left"><bold>SCOTT </bold>[<xref ref-type="bibr" rid="CR34">34</xref>]</td><td align="left">RCT</td><td align="left">Metastatic breast cancer</td><td align="left">65</td><td align="left">21&#x02013;80</td><td align="left">Aerobic training</td><td align="left"/><td align="left">3 d/week</td><td align="left">12 weeks</td><td align="left">12weeks</td></tr><tr><td align="left"><bold>TOSTI </bold>[<xref ref-type="bibr" rid="CR19">19</xref>]</td><td align="left">CT</td><td align="left">Breast cancer</td><td align="left">X</td><td align="left">25&#x02013;75</td><td align="left">Resistance training</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"><bold>YEE </bold>[<xref ref-type="bibr" rid="CR41">41</xref>]</td><td align="left">RCT (pilot)</td><td align="left">Metastatic breast cancer</td><td align="left">18</td><td align="left">&#x0203a;18</td><td align="left">Combined training</td><td align="left">80&#x02013;110 min/week</td><td align="left"><p>2 d/week</p><p>40&#x02013;55 min</p></td><td align="left">8 weeks</td><td align="left">8 weeks</td></tr><tr><td align="left"><bold>ZHIJUN </bold>[<xref ref-type="bibr" rid="CR42">42</xref>]</td><td align="left">RCT</td><td align="left">Breast cancer</td><td align="left">70</td><td align="left">43.1 (5.4)</td><td align="left">Aerobic training</td><td align="left"/><td align="left">50 min</td><td align="left">16 weeks</td><td align="left">16 weeks</td></tr></tbody></table><table-wrap-foot><p>Abbreviation: <italic>RCT</italic> randomised controlled trial, <italic>CT</italic> control trial</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Structural characteristics of the selected articles. &#x0201c;Cancer men and women&#x0201d;</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">TYPE OF STUDY</th><th align="left">TYPE OF CANCER</th><th align="left">PATIENTS</th><th align="left">AGE</th><th align="left">TYPE TRAINING</th><th align="left">TIME/WEEK</th><th align="left">DURATION OF SESSION<break/>FREQUENCY</th><th align="left">DURATION OF THE PROGRAM</th><th align="left">SUPERVISED EXERCISE TIME</th></tr></thead><tbody><tr><td align="left">BHATIA [<xref ref-type="bibr" rid="CR31">31</xref>]</td><td align="left">RCT</td><td align="left">Lung</td><td align="left">151</td><td align="left">64</td><td align="left">High intensity interval training</td><td align="left">90 min/week</td><td align="left"><p>30 min</p><p>3 d/week</p></td><td align="left">Mean 25 days</td><td align="left">25 days</td></tr><tr><td align="left">COURNEYA [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td align="left">RCT</td><td align="left">Colon</td><td align="left">211</td><td align="left">65</td><td align="left">Aerobic training</td><td align="left">x</td><td align="left">x</td><td align="left">3 years</td><td align="left">48 days</td></tr><tr><td align="left">EDVARDSEN [<xref ref-type="bibr" rid="CR35">35</xref>]</td><td align="left">RCT</td><td align="left">Lung</td><td align="left">106</td><td align="left">64.6</td><td align="left">Combined training</td><td align="left">240 min/week</td><td align="left"><p>60 min</p><p>3 d/week</p></td><td align="left">20 weeks</td><td align="left">20 weeks</td></tr><tr><td align="left">GRABENBAUER [<xref ref-type="bibr" rid="CR36">36</xref>]</td><td align="left">CT</td><td align="left"><p>Breast cancer</p><p>Colorectal cancer</p><p>Endometrial cancer</p><p>Brain tumour</p><p>Lymphoma</p></td><td align="left">52</td><td align="left">&#x0203a;18</td><td align="left">X</td><td align="left">90&#x02013;180 min/week</td><td align="left"><p>30&#x02013;60 min</p><p>3 d/week</p></td><td align="left">12 months</td><td align="left">12 weeks</td></tr><tr><td align="left">GROTE [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td align="left">CT</td><td align="left">Cancer survivors</td><td align="left">76</td><td align="left">X</td><td align="left">Combined training</td><td align="left">180 min/week</td><td align="left"><p>60 min</p><p>3 d/week</p></td><td align="left">26 weeks</td><td align="left"/></tr><tr><td align="left">NEILL [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td align="left">RCT</td><td align="left">Esophagogastric cancer</td><td align="left">45</td><td align="left">67.19</td><td align="left">Combined training</td><td align="left">210 min/week</td><td align="left"><p>35 min</p><p>6 d/weeks</p></td><td align="left">12 weeks</td><td align="left">10 weeks</td></tr><tr><td align="left">MAY [<xref ref-type="bibr" rid="CR32">32</xref>]</td><td align="left">RCT</td><td align="left">Cancer survivors</td><td align="left">176</td><td align="left">48.8</td><td align="left">Combined training</td><td align="left">260 min/week</td><td align="left"><p>120 min</p><p>2 d/week</p></td><td align="left">12 weeks</td><td align="left">12 weeks</td></tr><tr><td align="left">QUIST [<xref ref-type="bibr" rid="CR33">33</xref>]</td><td align="left">RCT</td><td align="left"><p>Breast cancer</p><p>Gynecological cancer</p><p>Others</p></td><td align="left">70</td><td align="left">18&#x02013;65</td><td align="left">Combined training</td><td align="left"><p>270 min/week</p><p>120 min/week</p></td><td align="left"><p>3 d/week</p><p>90 min</p><p>4 d/week (low intensity)</p><p>30 min</p></td><td align="left">6 weeks</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic>RCT</italic> randomised controlled trial, <italic>CT</italic> control trial</p></table-wrap-foot></table-wrap></p><p id="Par24">The results of the meta-analysis and the forest plot are shown in Figs. <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>. The heterogeneity of the effect sizes of the studies selected for the meta-analysis observed values of Q&#x02009;=&#x02009;35.47 and df&#x02009;=&#x02009;14. Furthermore, the results observed in the other heterogeneity test presented a moderate value (I2&#x02009;=&#x02009;33%). Specifically, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> shows the values obtained in the analysis carried out on men&#x02019;s cancer, both in the short and medium term. None of the included studies analysed the long-term effect of the intervention. The improvement ranges between 1.5 and 4.2% in male-associated cancer.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Forest plot of the effect on VO2max in male cancer patients in the short and medium term</p></caption><graphic xlink:href="520_2024_9004_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Forest plot of the effect on VO2max in female cancer patients in the short, medium, and long term</p></caption><graphic xlink:href="520_2024_9004_Fig3_HTML" id="MO3"/></fig></p><p id="Par25">On the other hand, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> shows the short-, medium- and long-term results of the effect of the intervention on female cancers. The articles selected have used different measurement instruments, but the most repeated were the Bruce Protocol and Treadmill Walking Test. Vo2max in female-associated cancer was measured at baseline, pre- and post-intervention. Vo2max has a range between&#x02009;&#x02212;&#x02009;0.3 and 53% in the experimental group.</p><p id="Par26">Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> shows Vo2max with the control group mean and case group mean. This variable is shown pre- and post-intervention. The cardiopulmonary exercise test is the most repeated measurement instrument amongst studies. Vo2max in men&#x02019;s and women&#x02019;s cancer was measured in baseline, short term, medium term and long term. The improvement ranges between&#x02009;&#x02212;&#x02009;0.72 and 14%.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Forest plot of the effect on VO2max in female-male cancer patients in the short, medium, and long term</p></caption><graphic xlink:href="520_2024_9004_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec8"><title>Discussion</title><p id="Par27">The main aim of this review was to analyse if VO2max in cancer patients increases after completing a TPE programme. The VO2max of the 2558 patients studied presents some variations by gender, intervention and moment of measurement. For male-associated cancer, the increased VO2max ranged between 1.5 and 4.2% after the intervention. With regard to diverse types of tumours related to women, the variable VO2max was measured in the short, medium and long term. The increase in VO2max in female-associated cancer was between 0.3 and 53% in the short term. In the medium term, it was between 0.9 and 16.8%, and in the long term between 2.9 and 12.7%. Types of cancer affecting both genders presented an oscillation between 2 and 3.47% in the short term, 0.5 and 4.1% in the medium term and 1.1 and 1.9% in the long term after intervention with the TPE programme.</p><sec id="Sec9"><title>Vo2max &#x0201c;men and cancer&#x0201d;</title><p id="Par28">Following analysis of four studies of male-associated tumours, three studies [<xref ref-type="bibr" rid="CR12">12</xref>,&#x000a0;<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR14">14</xref>] show an increase between 1.5 and 4.2% in VO2max consumption in the short term after intervention. In the medium term, the VO2max results for prostate cancer survivors did not show an increase in the experimental group after intervention [<xref ref-type="bibr" rid="CR15">15</xref>]. In the short term, the optimal frequency to generate an increase in VO2max in men with prostate and testicular cancer is 3 days a week [<xref ref-type="bibr" rid="CR12">12</xref>,&#x000a0;<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR14">14</xref>], with a duration per session equal to or longer than 35 min and with a minimum duration of the intervention protocol of 12 weeks and, preferably, supervised [<xref ref-type="bibr" rid="CR12">12</xref>,&#x000a0;<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR14">14</xref>]. Although, analysing the data well, it is also observed that the weekly intervention time should not be less than 105 min, there is a lack of studies that analyse how the intervention time should be distributed. In men with type II diabetes [<xref ref-type="bibr" rid="CR16">16</xref>] and healthy men [<xref ref-type="bibr" rid="CR17">17</xref>], participants&#x02019; VO2max increases with a frequency of 3 days per week. This increase in healthy men is 4.8% [<xref ref-type="bibr" rid="CR17">17</xref>], which is better than the increase for oncology patients. Similarly to healthy men [<xref ref-type="bibr" rid="CR17">17</xref>], high-intensity interval training (HIIT), supervised 3 days per week, achieves a higher increase in VO2max in men with prostate and testicular cancer [<xref ref-type="bibr" rid="CR13">13</xref>]. This increase is 4.2% [<xref ref-type="bibr" rid="CR13">13</xref>]. In the short term, all studies analysed [<xref ref-type="bibr" rid="CR12">12</xref>,&#x000a0;<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR14">14</xref>] present the same frequency (3 days per week), and these studies have a supervised intervention. In the non-oncology population, frequency and supervision of intervention are similar to the studies analysed [<xref ref-type="bibr" rid="CR16">16</xref>,&#x000a0;<xref ref-type="bibr" rid="CR17">17</xref>]. In addition, it is important to remark a minimum of training time per week. As to intensity of intervention, the authors believe it should be moderate&#x02013;high intensity [<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR17">17</xref>]. With high-intensity training, the authors obtain better results both in oncology patients [<xref ref-type="bibr" rid="CR13">13</xref>] and in healthy subjects [<xref ref-type="bibr" rid="CR17">17</xref>]. There are discrepancies as to the type of training, as well as the duration of the TPE programme. Future studies will be necessary to identify the most suitable type of training, as well as the most suitable duration of intervention to obtain a significant increase in male-associated VO2max. In the medium term, VO2max is measured by only one analysed study [<xref ref-type="bibr" rid="CR15">15</xref>], and this measurement does not vary after the intervention. This intervention presents a frequency of 2 days per week, is medium&#x02013;low intensity and is supervised [<xref ref-type="bibr" rid="CR15">15</xref>]. The frequency and intensity of this intervention are lower than other interventions studied [<xref ref-type="bibr" rid="CR12">12</xref>,&#x000a0;<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR14">14</xref>,&#x000a0;<xref ref-type="bibr" rid="CR16">16</xref>,&#x000a0;<xref ref-type="bibr" rid="CR17">17</xref>]. These factors may be the cause of the variable (VO2max) not showing an improvement.</p></sec><sec id="Sec10"><title>Vo2max &#x0201c;women and cancer&#x0201d;</title><p id="Par29">The results offered by 15 documents which analyse the change in VO2max in tumours associated with women are very disparate in the three measurement times (short term, medium term and long term). In the short term, the oscillation range of VO2max is between&#x02009;&#x02212;&#x02009;0.3 [<xref ref-type="bibr" rid="CR18">18</xref>] and 53% [<xref ref-type="bibr" rid="CR19">19</xref>]. Analysed studies have used combined training [<xref ref-type="bibr" rid="CR20">20</xref>,&#x000a0;<xref ref-type="bibr" rid="CR21">21</xref>], HIIT [<xref ref-type="bibr" rid="CR18">18</xref>,&#x000a0;<xref ref-type="bibr" rid="CR22">22</xref>] and strength training [<xref ref-type="bibr" rid="CR19">19</xref>]. The best improvement is obtained with strength training (55%) [<xref ref-type="bibr" rid="CR19">19</xref>]. An intervention with HIIT [<xref ref-type="bibr" rid="CR18">18</xref>] generates a deterioration in the experimental group, but this deterioration is less than for the control group. Despite these negative results [<xref ref-type="bibr" rid="CR18">18</xref>], the deterioration suffered by the control group is higher. These results reaffirm that doing TPE is a better option than not doing it in order to maintain cardiorespiratory function. Session time along with programme duration of this intervention [<xref ref-type="bibr" rid="CR18">18</xref>] is lower than those proposed by other authors [<xref ref-type="bibr" rid="CR19">19</xref>,&#x000a0;<xref ref-type="bibr" rid="CR20">20</xref>,&#x000a0;<xref ref-type="bibr" rid="CR21">21</xref>,&#x000a0;<xref ref-type="bibr" rid="CR22">22</xref>]. These factors may be the cause of deteriorating Vo2max in participants [<xref ref-type="bibr" rid="CR18">18</xref>]. The TPE programme that generates a clinically relevant improvement in VO2max in female cancer sufferers is the 24-week programme [<xref ref-type="bibr" rid="CR22">22</xref>]. The 24-week programme also generates a significant improvement in VO2max in women with fibromyalgia after intervention (17%) [<xref ref-type="bibr" rid="CR23">23</xref>]. The analysed studies offer a frequency between 2 and 3&#x000a0;days per week [<xref ref-type="bibr" rid="CR18">18</xref>,&#x000a0;<xref ref-type="bibr" rid="CR20">20</xref>,&#x000a0;<xref ref-type="bibr" rid="CR21">21</xref>]. The external literature offers the same frequency in postmenopausal women [<xref ref-type="bibr" rid="CR6">6</xref>], women with fibromyalgia [<xref ref-type="bibr" rid="CR23">23</xref>], obese women [<xref ref-type="bibr" rid="CR24">24</xref>] and postmenopausal women [<xref ref-type="bibr" rid="CR25">25</xref>]. There is controversy about some important factors in planning TPE programmes (intensity and type training) in women with cancer. This controversy is due to the lack of information regarding intensity, as intensity of intervention is offered by only two [<xref ref-type="bibr" rid="CR18">18</xref>,&#x000a0;<xref ref-type="bibr" rid="CR22">22</xref>] to five studies analysed. The controversy is also due to the type of training, as the authors use four different types in their interventions. Future studies will be necessary to identify the type of training, as well as the intensity of training suitable for tumours associated with women.</p><p id="Par30">In the medium term, all interventions show improvements in the VO2max of their participants, oscillating between 0.9 [<xref ref-type="bibr" rid="CR20">20</xref>] and 16.8% [<xref ref-type="bibr" rid="CR26">26</xref>]. It would seem that, in the medium term, the type of training that generates major benefits in VO2max is combined training (between 0.9 and 16.8%). This type of training is used by five to seven studies analysed [<xref ref-type="bibr" rid="CR20">20</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR27">27</xref>,&#x000a0;<xref ref-type="bibr" rid="CR28">28</xref>,&#x000a0;<xref ref-type="bibr" rid="CR29">29</xref>]. There is a slight controversy as to the supervision of TPE programme, as the intervention proposed by Mcneil [<xref ref-type="bibr" rid="CR22">22</xref>] is not supervised, and this intervention shows an increase between 3.2 and 4% in the VO2max of participants. These results are lower than those observed in supervised interventions, which show improvements that oscillate between 0.9 [<xref ref-type="bibr" rid="CR20">20</xref>] and 16.8% [<xref ref-type="bibr" rid="CR28">28</xref>]. Furthermore, the improvement in participants in the programme proposed by Mcneil [<xref ref-type="bibr" rid="CR22">22</xref>] shows a deterioration in the medium term, which may be due to the non-supervision of the intervention, as the rest of the interventions are supervised and their improvement in VO2max is maintained over time [<xref ref-type="bibr" rid="CR20">20</xref>]. As is the case with female cancer sufferers [<xref ref-type="bibr" rid="CR25">25</xref>], the supervised intervention for postmenopausal women shows an increase of 6.4% in the VO2max of participants. In obese breast cancer survivors [<xref ref-type="bibr" rid="CR24">24</xref>], the improvement is more discreet after the supervised intervention, and corporal mass index could be an influential factor in the improvement of VO2max. The frequency of the intervention in postmenopausal [<xref ref-type="bibr" rid="CR25">25</xref>] women and obese breast cancer survivors [<xref ref-type="bibr" rid="CR24">24</xref>] is 2&#x02013;3&#x000a0;days per week. This frequency is proposed by the majority of authors to increase VO2max in cancer sufferers [<xref ref-type="bibr" rid="CR20">20</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR27">27</xref>,&#x000a0;<xref ref-type="bibr" rid="CR28">28</xref>,&#x000a0;<xref ref-type="bibr" rid="CR29">29</xref>]. It appears that frequency and supervision are two influential factors in planning a TPE programme in women with cancer in order to achieve an improvement in their VO2max. In 2019, The American Cancer Society [<xref ref-type="bibr" rid="CR7">7</xref>] updated a review with more than 13,000 cancer patients, including breast cancer sufferers. This review shows that more than 75% of programmes are supervised by a health professional [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par31">In the long term, only 4 of the 15 studies analysed offer measurements [<xref ref-type="bibr" rid="CR20">20</xref>,&#x000a0;<xref ref-type="bibr" rid="CR27">27</xref>,&#x000a0;<xref ref-type="bibr" rid="CR28">28</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>]. VO2max shows an improvement between 2.9 and 12.7% after intervention with TPE. The type of training most repeated by the authors is combined training [<xref ref-type="bibr" rid="CR20">20</xref>] [<xref ref-type="bibr" rid="CR27">27</xref>] [<xref ref-type="bibr" rid="CR28">28</xref>], although the major increase in VO2max (12.7%) is obtained with aerobic training [<xref ref-type="bibr" rid="CR30">30</xref>]. In a similar population, the intervention with postmenopausal women [<xref ref-type="bibr" rid="CR6">6</xref>] is also with aerobic training, which could be the most suitable to increase VO2max in women in the long term. The disparity in the four studies analysed [<xref ref-type="bibr" rid="CR20">20</xref>,&#x000a0;<xref ref-type="bibr" rid="CR27">27</xref>,&#x000a0;<xref ref-type="bibr" rid="CR28">28</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>] may be due to two factors: time of session and duration of the programme. The authors propose a time of session between 38 [<xref ref-type="bibr" rid="CR27">27</xref>] and 90 min [<xref ref-type="bibr" rid="CR20">20</xref>]. The best increase in VO2max is obtained within 45 min of the session [<xref ref-type="bibr" rid="CR30">30</xref>], and this increase generated an improvement of 12.7% in the vo2max of participants. With regard to the duration of the intervention, the authors propose a duration of between 12 [<xref ref-type="bibr" rid="CR27">27</xref>] and 48 weeks [<xref ref-type="bibr" rid="CR30">30</xref>]; a 48-week duration shows an increase of 12.7% [<xref ref-type="bibr" rid="CR30">30</xref>], followed by an improvement of 8.8% for 16 weeks [<xref ref-type="bibr" rid="CR28">28</xref>]. It would appear that a major increase in VO2max of the participants requires the intervention to last more than 12 weeks. It would be interesting for future studies to show all influential factors in a TPE programme (frequency, intensity, type of training, time of session and duration of intervention) to achieve a significant increase in VO2max in women in the long term.</p></sec><sec id="Sec11"><title>Vo2max &#x0201c;male and female cancer&#x0201d;</title><p id="Par32">In the short term, five studies that analysed males and females with cancer present an increase in VO2max between&#x02009;&#x02212;&#x02009;0.75 [<xref ref-type="bibr" rid="CR9">9</xref>] and 14% [<xref ref-type="bibr" rid="CR31">31</xref>]. After a supervised HIIT in lung cancer patients, there is an improvement of 14% in VO2max [<xref ref-type="bibr" rid="CR31">31</xref>]. However, the most repeated training is combined training, which shows an improvement of&#x02009;&#x02212;&#x02009;0.72% [<xref ref-type="bibr" rid="CR9">9</xref>], 3.7% [<xref ref-type="bibr" rid="CR10">10</xref>], 2.5% [<xref ref-type="bibr" rid="CR32">32</xref>] and 2.9% [<xref ref-type="bibr" rid="CR33">33</xref>]. Despite being the most repeated training, Grote [<xref ref-type="bibr" rid="CR9">9</xref>] offers negative results after the intervention. Non-supervision could be the cause of a decrease in VO2max after the TAPE programme [<xref ref-type="bibr" rid="CR9">9</xref>], as the other authors obtain improvement in VO2max after a supervised intervention [<xref ref-type="bibr" rid="CR10">10</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>,&#x000a0;<xref ref-type="bibr" rid="CR32">32</xref>]. In the short term, two influential factors in the increase in VO2max, both in the oncological population and in the healthy population, are supervision in the programme and the high intensity of the training. In cancer patients [<xref ref-type="bibr" rid="CR24">24</xref>], active healthy population [<xref ref-type="bibr" rid="CR17">17</xref>] and inactive healthy population [<xref ref-type="bibr" rid="CR6">6</xref>], we can see that the supervised intervention brings better results in the increase in participants&#x02019; VO2max. A supervised intervention shows an increase of 0.1% in obese breast cancer survivors [<xref ref-type="bibr" rid="CR34">34</xref>], an increase of 4.8% in healthy men [<xref ref-type="bibr" rid="CR17">17</xref>] and an increase of 0.17% in postmenopausal women with low physical activity [<xref ref-type="bibr" rid="CR6">6</xref>]. As with the oncological population [<xref ref-type="bibr" rid="CR13">13</xref>], in the healthy population [<xref ref-type="bibr" rid="CR17">17</xref>] [<xref ref-type="bibr" rid="CR25">25</xref>], a major increase in VO2max is obtained with a high-intensity dose in training. With a high-intensity intervention, the authors obtain an increase of 6.4% in premenopausal women&#x02019;s VO2max [<xref ref-type="bibr" rid="CR25">25</xref>] and an increase of 4.8% [<xref ref-type="bibr" rid="CR17">17</xref>] in healthy men. This factor (high intensity) is recommended to improve other adverse effects of cancer. &#x0201c;Exercise guideline for cancer survivors&#x0201d; [<xref ref-type="bibr" rid="CR8">8</xref>] recommends high intensity in training to decrease anxiety, depression and lymphoedema. Training with high intensity also increases the quality of life and physical function of patients [<xref ref-type="bibr" rid="CR8">8</xref>]<italic>.</italic> In the medium term, four studies take measurements after intervention, obtaining an improvement range in VO2max between&#x02009;&#x02212;&#x02009;0.2 [<xref ref-type="bibr" rid="CR9">9</xref>] and 4.1% [<xref ref-type="bibr" rid="CR35">35</xref>]. The most repeated training is combined training with a frequency of 3&#x000a0;days per week and 60&#x000a0;min per session [<xref ref-type="bibr" rid="CR9">9</xref>,&#x000a0;<xref ref-type="bibr" rid="CR10">10</xref>,&#x000a0;<xref ref-type="bibr" rid="CR35">35</xref>]. All experimental group results are positive. In contrast, Grote [<xref ref-type="bibr" rid="CR9">9</xref>] proposes an intervention with combined training, but this intervention produces a decrease of 0.2% in VO2max. As in the short term, this decrease in VO2max could be due to the non-supervised intervention, as TPE is most effective if it is supervised by a health professional [<xref ref-type="bibr" rid="CR7">7</xref>]. In the medium term, the effectiveness of the supervision programme could also be observed in obese breast cancer survivors [<xref ref-type="bibr" rid="CR24">24</xref>] and in low-level physical activity postmenopausal women [<xref ref-type="bibr" rid="CR6">6</xref>]. In both interventions, VO2max is maintained between 0.1 and 17% [<xref ref-type="bibr" rid="CR6">6</xref>,&#x000a0;<xref ref-type="bibr" rid="CR24">24</xref>]. Another influential factor in the decreased VO2max of the experimental group in Grote&#x02019;s intervention [<xref ref-type="bibr" rid="CR9">9</xref>] is the duration of the intervention (26 weeks). This duration is infrequent, as it is 12&#x000a0;weeks or 12&#x000a0;months in both the oncological population [<xref ref-type="bibr" rid="CR10">10</xref>,&#x000a0;<xref ref-type="bibr" rid="CR36">36</xref>] and the non-oncological population [<xref ref-type="bibr" rid="CR6">6</xref>,&#x000a0;<xref ref-type="bibr" rid="CR24">24</xref>]. With regard to the most repeated frequency in the analysed studies, 3&#x000a0;days per week generates an increase in the VO2max of participants [<xref ref-type="bibr" rid="CR9">9</xref>,&#x000a0;<xref ref-type="bibr" rid="CR35">35</xref>,&#x000a0;<xref ref-type="bibr" rid="CR36">36</xref>]. This frequency (3&#x000a0;days per week) is used in men with type II diabetes [<xref ref-type="bibr" rid="CR16">16</xref>] and healthy subjects [<xref ref-type="bibr" rid="CR6">6</xref>,&#x000a0;<xref ref-type="bibr" rid="CR17">17</xref>,&#x000a0;<xref ref-type="bibr" rid="CR25">25</xref>], and all these interventions show an increase in VO2max of their participants.</p><p id="Par33">In the long term, only two studies analyse changes in VO2max [<xref ref-type="bibr" rid="CR36">36</xref>,&#x000a0;<xref ref-type="bibr" rid="CR37">37</xref>].Vo2max improves by 1.9% with a supervised intervention of 3 days per week [<xref ref-type="bibr" rid="CR36">36</xref>], and with anaerobic training for 3 years, VO2max improves by 1.1% [<xref ref-type="bibr" rid="CR37">37</xref>]. There is a disparity in influential factors in the TPE programme which have been proposed by the authors [<xref ref-type="bibr" rid="CR36">36</xref>,&#x000a0;<xref ref-type="bibr" rid="CR37">37</xref>]. However, the 12-month programme for cancer patients [<xref ref-type="bibr" rid="CR36">36</xref>] is the same duration as the authors propose for low-level physical activity in postmenopausal women [<xref ref-type="bibr" rid="CR6">6</xref>]. For this healthy population, the intervention consists of aerobic training, which is the same type of training as for colonic patients [<xref ref-type="bibr" rid="CR37">37</xref>]. It would appear that aerobic training and 12 months of duration are two factors to produce an increase in VO2max in the long term [<xref ref-type="bibr" rid="CR6">6</xref>,&#x000a0;<xref ref-type="bibr" rid="CR36">36</xref>,&#x000a0;<xref ref-type="bibr" rid="CR37">37</xref>]. It would be interesting for future studies to contemplate an evolution in the intervention in order to maintain a stimulus that generates changes in the patients.</p></sec></sec><sec id="Sec12"><title>Clinical applicability</title><p id="Par34">The studies with the best results show an increase in the participants&#x02019; VO2max of between 4.2 [<xref ref-type="bibr" rid="CR13">13</xref>] and 53% [<xref ref-type="bibr" rid="CR19">19</xref>]. All study populations present results in the short term [<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR19">19</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>], but only studies about women and cancer [<xref ref-type="bibr" rid="CR19">19</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>] show clinically relevant improvements in the medium and long term. These studies present some common influential factors in planning a TPE programme. The most repeated frequency is 3 days per week [<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>] and the mean duration of the session is 45 min [<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>]. All authors propose vigorous intensity training [<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR19">19</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>]. With regard to the duration of the TPE programme, the most notable is 12 weeks [<xref ref-type="bibr" rid="CR13">13</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>] and all authors supervise the intervention [<xref ref-type="bibr" rid="CR38">38</xref>,&#x000a0;<xref ref-type="bibr" rid="CR19">19</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>]. As for type of training, there is a major disparity due to diversity in the study population, but the most repeated type of training is HIIT [<xref ref-type="bibr" rid="CR38">38</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>]. Of the studies with best results in VO2max, all participants accumulate a mean of 150 min of exercise per week [<xref ref-type="bibr" rid="CR38">38</xref>,&#x000a0;<xref ref-type="bibr" rid="CR19">19</xref>,&#x000a0;<xref ref-type="bibr" rid="CR26">26</xref>,&#x000a0;<xref ref-type="bibr" rid="CR30">30</xref>,&#x000a0;<xref ref-type="bibr" rid="CR31">31</xref>]. Additionally, another variable that must be taken into account is the intensity of the exercise. In this sense, although few studies have made a direct comparison between the effect of the same intervention at different intensities, in the one that has done so, it has been observed how higher intensities achieve better results in increasing VO2max with respect to the lowest intensities [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par35">It is important to highlight supervision of intervention to guarantee the safety and efficacy of the TPE programme, regardless of cancer type.</p><p id="Par36">For male-associated cancer, the most suitable frequency will be 3 days per week with a minimum duration of 35 min. The intensity should be moderate-vigorous and the duration of the programme should be 12 weeks. As for type of training for men with testicular cancer, HIIT would be of particular interest, while for men with prostate cancer, the type would be aerobic training.</p><p id="Par37">In female cancer types, the most repeated are breast cancer and metastatic breast cancer. In the short term, the most suitable type of training for breast cancer participants would be strength training. This shows improvements in VO2max in breast cancer participants. In the medium term, the type of training should be combined training (strength and aerobic training), 3 days per week, with moderate-vigorous intensity and a programme duration of 12 weeks. To maintain VO2max benefits in breast cancer sufferers in the long term, the training should be aerobic and the frequency 5 days per week with a programme duration of 48 weeks. In metastatic breast cancer women, the results of the studies offer an aerobic programme with medium&#x02013;high intensity, 3 days per week and a programme duration of 12 weeks.</p><p id="Par38">With regard to cancers associated with both genders, we note the third most frequent tumour in Spain in 2022, namely lung cancer. An HIIT would be interesting for this type of cancer, 3 days per week with a minimum duration of 30 min.</p><p id="Par39">Other adverse effects can influence the improvement in VO2max in oncology patients. An exclusive TPE intervention might not resolve these effects. A multidisciplinary intervention with exercise, nutrition and psychology could contemplate all these adverse effects. For example, high corporal mass index, as well as emotional distress, can interfere with the improvement in VO2max in cancer patients who have been intervened with TPE. For head and neck cancer (HNC) patients with radiotherapy treatment [<xref ref-type="bibr" rid="CR5">5</xref>], a nutritional and psychological education intervention shows numerous benefits. HNC patients improve their nutritional state, quality of life, weight, depression and the interruption periods of radiotherapy treatment [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par40">The American Cancer Society [<xref ref-type="bibr" rid="CR5">5</xref>] shows the recommendations for nutrition and physical activity in oncology patients. Experts recommend a combined intervention with both therapies to prevent a primary tumour for patients with oncology treatment and survivors [<xref ref-type="bibr" rid="CR5">5</xref>]. A multidisciplinary intervention in oncology patients to achieve greater benefits would therefore be interesting.</p></sec><sec id="Sec13"><title>Strengths and weaknesses</title><p id="Par41">Those studies published in five languages (English, Spanish, Italian, French and Portuguese) were selected, although there may be other papers which are not included in the present review. Despite the search having been carried out in four leading databases, there could be other studies in other databases which have not been included in the present review.</p></sec><sec id="Sec14"><title>Conclusions</title><p id="Par42">TPE is an efficient intervention to improve VO2max in oncology patients. TPE intervention should be supervised by health professionals, regardless of gender and type of cancer. The results in this review show that a TPE intervention lasting 12 weeks, 3 days per week with a moderate-vigorous intensity, increases VO2max in oncology patients. However, future studies would be necessary to evaluate the type of training that is most adequate according to gender and type of cancer. Studies carrying out measurements in the medium and long term of VO2max in participants would also be necessary.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Assistance provided by C&#x000e1;tedra de Fisioterapia of Universidad de Malaga was greatly appreciated.</p></ack><notes notes-type="author-contribution"><title>Author contribution</title><p>Conceptualization: Alicia Del Rosal Jurado, Manuel Gonz&#x000e1;lez S&#x000e1;nchez y Antonio I. Cuesta Vargas; Methodology: Alicia Del Rosal y Manuel Gonz&#x000e1;lez S&#x000e1;nchez; Formal analysis and investigation: Manuel Gonz&#x000e1;lez S&#x000e1;nchez y Antonio I. Cuesta Vargas; Writing&#x02014;original draft preparation: Alicia Del Rosal Jurado; Writing&#x02014;review and editing: Alicia Del Rosal Jurado y Manuel Gonz&#x000e1;lez S&#x000e1;nchez; Supervision: Manuel Gonz&#x000e1;lez S&#x000e1;nchez y Antonio I. Cuesta Vargas.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Funding for open access publishing: Universidad de M&#x000e1;laga/CBUA.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data are availability under request to the corresponding author.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par43">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Sociedad Espa&#x000f1;ola de Oncologia M&#x000e9;dica (SEOM). Cifras del c&#x000e1;ncer en espa&#x000f1;a (2021) 2021. 36 p.</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Repka</surname><given-names>CP</given-names></name><name><surname>Peterson</surname><given-names>BM</given-names></name><name><surname>Brown</surname><given-names>JM</given-names></name><name><surname>Lalonde</surname><given-names>TL</given-names></name><name><surname>Schneider</surname><given-names>CM</given-names></name><name><surname>Hayward</surname><given-names>R</given-names></name></person-group><article-title>Cancer type does not affect exercise-mediated improvements in cardiorespiratory function and fatigue</article-title><source>Integr Cancer Ther</source><year>2014</year><volume>13</volume><issue>6</issue><fpage>473</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1177/1534735414547108</pub-id><pub-id pub-id-type="pmid">25148839</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Repka CP, Peterson BM, Brown JM, Lalonde TL, Schneider CM, Hayward R (2014) Cancer type does not affect exercise-mediated improvements in cardiorespiratory function and fatigue. Integr Cancer Ther 13(6):473&#x02013;481<pub-id pub-id-type="pmid">25148839</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Katsura C, Ogunmwonyi I, Saha S, Katsura C (2024) Doctors in training breast cancer&#x0202f;: presentation, investigation and management 1-7</mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Ferlay J, Rebecca ME, Mph LS (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries 229&#x02013;63.</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Rock CL, Thomson CA, Sullivan KR, Howe CL, Kushi LH, Caan BJ et&#x000a0;al (2022) American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin 0(0):1&#x02013;33</mixed-citation></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Boyne</surname><given-names>DJ</given-names></name><name><surname>King</surname><given-names>WD</given-names></name><name><surname>Brenner</surname><given-names>DR</given-names></name><name><surname>McIntyre</surname><given-names>JB</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>Friedenreich</surname><given-names>CM</given-names></name></person-group><article-title>Aerobic exercise and DNA methylation in postmenopausal women: an ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><issue>6</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0198641</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Boyne DJ, King WD, Brenner DR, McIntyre JB, Courneya KS, Friedenreich CM (2018) Aerobic exercise and DNA methylation in postmenopausal women: an ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial. PLoS ONE 13(6):1&#x02013;13</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>KH</given-names></name><name><surname>Campbell</surname><given-names>AM</given-names></name><name><surname>Stuiver</surname><given-names>MM</given-names></name><name><surname>Pinto</surname><given-names>BM</given-names></name><name><surname>Schwartz</surname><given-names>AL</given-names></name><name><surname>Morris</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Exercise is medicine in oncology: engaging clinicians to help patients move through cancer</article-title><source>CA Cancer J Clin</source><year>2019</year><volume>69</volume><issue>6</issue><fpage>468</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.3322/caac.21579</pub-id><pub-id pub-id-type="pmid">31617590</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS et al (2019) Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin 69(6):468&#x02013;484<pub-id pub-id-type="pmid">31617590</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>KL</given-names></name><name><surname>Winters-stone</surname><given-names>KM</given-names></name><name><surname>Wiskemann</surname><given-names>J</given-names></name><name><surname>May</surname><given-names>AM</given-names></name><name><surname>Schwartz</surname><given-names>AL</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Exercise guidelines for cancer survivors</article-title><source>Med Sci Sports Exercise</source><year>2019</year><volume>51</volume><fpage>2375</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000002116</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Campbell KL, Winters-stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS et al (2019) Exercise guidelines for cancer survivors. Med Sci Sports Exercise 51:2375&#x02013;90</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Grote S, Ricci JM, Dehom S, Modeste N, Sealy DA, Tarleton HP (2020) Heart rate variability and cardiovascular adaptations among cancer-survivors following a 26-week exercise intervention. Integr Cancer Ther 19. 10.1177/1534735420969816</mixed-citation></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Neill</surname><given-names>LMO</given-names></name><name><surname>Guinan</surname><given-names>&#x000c3;E</given-names></name><name><surname>Doyle</surname><given-names>SL</given-names></name><name><surname>Bennett</surname><given-names>AE</given-names></name><name><surname>Murphy</surname><given-names>C</given-names></name><name><surname>Elliott</surname><given-names>JA</given-names></name><etal/></person-group><article-title>The RESTORE randomized controlled trial impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship</article-title><source>Annals Surg</source><year>2018</year><volume>268</volume><issue>5</issue><fpage>747</fpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000002895</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Neill LMO, Guinan &#x000c3;E, Doyle SL, Bennett AE, Murphy C, Elliott JA et al (2018) The RESTORE randomized controlled trial impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship. Annals Surg 268(5):747</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Higgins J, Thompson S, Deeks J, Altman D (2002) Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy [Internet]. 1 de enero de 7(1):51&#x02013;61. Disponible en: 10.1258/1355819021927674</mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Hvid</surname><given-names>T</given-names></name><name><surname>Winding</surname><given-names>K</given-names></name><name><surname>Rinnov</surname><given-names>A</given-names></name><name><surname>Dejgaard</surname><given-names>T</given-names></name><name><surname>Thomsen</surname><given-names>C</given-names></name><name><surname>Iversen</surname><given-names>P</given-names></name><etal/></person-group><article-title>Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy</article-title><source>Endocrine-Related Cancer</source><year>2013</year><volume>20</volume><fpage>621</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1530/ERC-12-0393</pub-id><pub-id pub-id-type="pmid">23744766</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Hvid T, Winding K, Rinnov A, Dejgaard T, Thomsen C, Iversen P et al (2013) Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy. Endocrine-Related Cancer 20:621&#x02013;32<pub-id pub-id-type="pmid">23744766</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>SC</given-names></name><name><surname>Segal</surname><given-names>RJ</given-names></name><name><surname>McKenzie</surname><given-names>DC</given-names></name><name><surname>Vallerand</surname><given-names>JR</given-names></name><name><surname>Morielli</surname><given-names>AR</given-names></name><name><surname>Mackey</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial</article-title><source>Breast Cancer Res Treat</source><year>2016</year><volume>158</volume><issue>3</issue><fpage>497</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1007/s10549-016-3900-2</pub-id><pub-id pub-id-type="pmid">27394134</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Adams SC, Segal RJ, McKenzie DC, Vallerand JR, Morielli AR, Mackey JR et al (2016) Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. Breast Cancer Res Treat 158(3):497&#x02013;507<pub-id pub-id-type="pmid">27394134</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Uth</surname><given-names>J</given-names></name><name><surname>Hornstrup</surname><given-names>T</given-names></name><name><surname>Schmidt</surname><given-names>JF</given-names></name><name><surname>Christensen</surname><given-names>JF</given-names></name><name><surname>Frandsen</surname><given-names>C</given-names></name><name><surname>Christensen</surname><given-names>KB</given-names></name><etal/></person-group><article-title>Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy</article-title><source>Scand J Med Sci Sport.</source><year>2014</year><volume>24</volume><issue>SUPPL 1</issue><fpage>105</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/sms.12260</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Uth J, Hornstrup T, Schmidt JF, Christensen JF, Frandsen C, Christensen KB et al (2014) Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy. Scand J Med Sci Sport. 24(SUPPL 1):105&#x02013;12</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>BA</given-names></name><name><surname>Galv&#x000e3;o</surname><given-names>DA</given-names></name><name><surname>Fatehee</surname><given-names>N</given-names></name><name><surname>Taaffe</surname><given-names>DR</given-names></name><name><surname>Spry</surname><given-names>N</given-names></name><name><surname>Joseph</surname><given-names>D</given-names></name><etal/></person-group><article-title>Exercise improves VO2max and body composition in androgen deprivation therapy-treated prostate cancer patients</article-title><source>Med Sci Sports Exerc</source><year>2017</year><volume>49</volume><issue>8</issue><fpage>1503</fpage><lpage>1510</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000001277</pub-id><pub-id pub-id-type="pmid">28319589</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Wall BA, Galv&#x000e3;o DA, Fatehee N, Taaffe DR, Spry N, Joseph D et al (2017) Exercise improves VO2max and body composition in androgen deprivation therapy-treated prostate cancer patients. Med Sci Sports Exerc 49(8):1503&#x02013;1510<pub-id pub-id-type="pmid">28319589</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Florida N, L&#x000f3;pez C, Pocomucha V. CORE View metadata, citation and similar papers at core.ac.uk. 2012;2(2):35&#x02013;43.</mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Arboleda-Serna</surname><given-names>VH</given-names></name><name><surname>Feito</surname><given-names>Y</given-names></name><name><surname>Pati&#x000f1;o-Villada</surname><given-names>FA</given-names></name><name><surname>Vargas-Romero</surname><given-names>AV</given-names></name><name><surname>Arango-V&#x000e9;lez</surname><given-names>EF</given-names></name></person-group><article-title>Effects of high-intensity interval training compared to moderate-intensity continuous training on maximal oxygen consumption and blood pressure in healthy men: a randomized controlled trial</article-title><source>Biomedica</source><year>2019</year><volume>39</volume><issue>3</issue><fpage>524</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.7705/biomedica.4451</pub-id><pub-id pub-id-type="pmid">31584766</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Arboleda-Serna VH, Feito Y, Pati&#x000f1;o-Villada FA, Vargas-Romero AV, Arango-V&#x000e9;lez EF (2019) Effects of high-intensity interval training compared to moderate-intensity continuous training on maximal oxygen consumption and blood pressure in healthy men: a randomized controlled trial. Biomedica 39(3):524&#x02013;536<pub-id pub-id-type="pmid">31584766</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>I</given-names></name><name><surname>Mack</surname><given-names>WJ</given-names></name><name><surname>Mortimer</surname><given-names>J</given-names></name><name><surname>Sattler</surname><given-names>F</given-names></name><name><surname>Salem</surname><given-names>G</given-names></name><etal/></person-group><article-title>Feasibility of high intensity interval training in patients with breast cancer undergoing anthracycline chemotherapy: a randomized pilot trial</article-title><source>BMC Cancer</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s12885-019-5887-7</pub-id><pub-id pub-id-type="pmid">30606139</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Lee K, Kang I, Mack WJ, Mortimer J, Sattler F, Salem G et al (2019) Feasibility of high intensity interval training in patients with breast cancer undergoing anthracycline chemotherapy: a randomized pilot trial. BMC Cancer 19(1):1&#x02013;9<pub-id pub-id-type="pmid">30606139</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Tosti</surname><given-names>KP</given-names></name><name><surname>Hackney</surname><given-names>AC</given-names></name><name><surname>Battaglini</surname><given-names>CL</given-names></name><name><surname>Evans</surname><given-names>ES</given-names></name><name><surname>Groff</surname><given-names>D</given-names></name></person-group><article-title>Exercise in patients with breast cancer and healthy controls: energy substrate oxidation and blood lactate responses</article-title><source>Integr Cancer Ther</source><year>2011</year><volume>10</volume><issue>1</issue><fpage>6</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1177/1534735410387600</pub-id><pub-id pub-id-type="pmid">21147819</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Tosti KP, Hackney AC, Battaglini CL, Evans ES, Groff D (2011) Exercise in patients with breast cancer and healthy controls: energy substrate oxidation and blood lactate responses. Integr Cancer Ther 10(1):6&#x02013;15<pub-id pub-id-type="pmid">21147819</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">de Paulo TRS, Winters-Stone KM, Viezel J, Rossi FE, Aro BL, Trindade ACAC et&#x000a0;al (2019) Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women. Disabil Rehabil [Internet] 41(18):2175&#x02013;82. Disponible en: 10.1080/09638288.2018.1460877</mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Mehnert</surname><given-names>A</given-names></name><name><surname>Veers</surname><given-names>S</given-names></name><name><surname>Howaldt</surname><given-names>D</given-names></name><name><surname>Braumann</surname><given-names>KM</given-names></name><name><surname>Koch</surname><given-names>U</given-names></name><name><surname>Schulz</surname><given-names>KH</given-names></name></person-group><article-title>Effects of a physical exercise rehabilitation group program on anxiety, depression, body image, and health-related quality of life among breast cancer patients</article-title><source>Onkologie</source><year>2011</year><volume>34</volume><issue>5</issue><fpage>248</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1159/000327813</pub-id><pub-id pub-id-type="pmid">21577030</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Mehnert A, Veers S, Howaldt D, Braumann KM, Koch U, Schulz KH (2011) Effects of a physical exercise rehabilitation group program on anxiety, depression, body image, and health-related quality of life among breast cancer patients. Onkologie 34(5):248&#x02013;253<pub-id pub-id-type="pmid">21577030</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>McNeil</surname><given-names>J</given-names></name><name><surname>Brenner</surname><given-names>DR</given-names></name><name><surname>Stone</surname><given-names>CR</given-names></name><name><surname>O&#x02019;Reilly</surname><given-names>R</given-names></name><name><surname>Ruan</surname><given-names>Y</given-names></name><name><surname>Vallance</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Activity tracker to prescribe various exercise intensities in breast cancer survivors</article-title><source>Med Sci Sports Exerc</source><year>2019</year><volume>51</volume><issue>5</issue><fpage>930</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000001890</pub-id><pub-id pub-id-type="pmid">30694978</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">McNeil J, Brenner DR, Stone CR, O&#x02019;Reilly R, Ruan Y, Vallance JK et al (2019) Activity tracker to prescribe various exercise intensities in breast cancer survivors. Med Sci Sports Exerc 51(5):930&#x02013;940<pub-id pub-id-type="pmid">30694978</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Villafaina</surname><given-names>S</given-names></name><name><surname>Borrega-mouquinho</surname><given-names>Y</given-names></name><name><surname>Fuentes-garc&#x000ed;a</surname><given-names>JP</given-names></name><name><surname>Collado-mateo</surname><given-names>D</given-names></name><name><surname>Gusi</surname><given-names>N</given-names></name></person-group><article-title>Effect of exergame training and detraining on lower-body strength, agility, and cardiorespiratory fitness in women with fibromyalgia: single-blinded randomized controlled trial</article-title><source>Int J Environ Res Public Health.</source><year>2020</year><volume>17</volume><issue>1</issue><fpage>161</fpage><pub-id pub-id-type="doi">10.3390/ijerph17010161</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Villafaina S, Borrega-mouquinho Y, Fuentes-garc&#x000ed;a JP, Collado-mateo D, Gusi N (2020) Effect of exergame training and detraining on lower-body strength, agility, and cardiorespiratory fitness in women with fibromyalgia: single-blinded randomized controlled trial. Int J Environ Res Public Health. 17(1):161</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Melnick</surname><given-names>AL</given-names></name><name><surname>Sheng</surname><given-names>MC</given-names></name></person-group><article-title>The feasibility and acceptability of a diet and exercise trial in overweight and obese black breast cancer survivors: the stepping STONE study HHS Public Access</article-title><source>Physiol Behav</source><year>2016</year><volume>176</volume><issue>1</issue><fpage>100</fpage><lpage>106</lpage></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Melnick AL, Sheng MC, (2016) The feasibility and acceptability of a diet and exercise trial in overweight and obese black breast cancer survivors: the stepping STONE study HHS Public Access. Physiol Behav 176(1):100&#x02013;106</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Buyukyazi</surname><given-names>G</given-names></name><name><surname>Ulman</surname><given-names>C</given-names></name><name><surname>&#x000c7;elik</surname><given-names>A</given-names></name><name><surname>&#x000c7;etinkaya</surname><given-names>C</given-names></name><name><surname>Sisman</surname><given-names>AR</given-names></name><name><surname>&#x000c7;imrin</surname><given-names>D</given-names></name><etal/></person-group><article-title>The effect of 8-week different-intensity walking exercises on serum hepcidin, IL-6, and iron metabolism in pre-menopausal women</article-title><source>Physiol Int</source><year>2017</year><volume>104</volume><issue>1</issue><fpage>52</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1556/2060.104.2017.1.7</pub-id><pub-id pub-id-type="pmid">28361576</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Buyukyazi G, Ulman C, &#x000c7;elik A, &#x000c7;etinkaya C, Sisman AR, &#x000c7;imrin D et al (2017) The effect of 8-week different-intensity walking exercises on serum hepcidin, IL-6, and iron metabolism in pre-menopausal women. Physiol Int 104(1):52&#x02013;63<pub-id pub-id-type="pmid">28361576</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Dieli-Conwright</surname><given-names>CM</given-names></name><name><surname>Fox</surname><given-names>FS</given-names></name><name><surname>Tripathy</surname><given-names>D</given-names></name><name><surname>Sami</surname><given-names>N</given-names></name><name><surname>Van Fleet</surname><given-names>J</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise on physical fitness and quality-of-life in breast cancer survivors</article-title><source>J Cancer Surviv</source><year>2021</year><volume>15</volume><issue>1</issue><fpage>127</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1007/s11764-020-00918-3</pub-id><pub-id pub-id-type="pmid">32681303</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Dieli-Conwright CM, Fox FS, Tripathy D, Sami N, Van Fleet J, Buchanan TA et al (2021) Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise on physical fitness and quality-of-life in breast cancer survivors. J Cancer Surviv 15(1):127&#x02013;139<pub-id pub-id-type="pmid">32681303</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Casla</surname><given-names>S</given-names></name><name><surname>L&#x000f3;pez-Tarruella</surname><given-names>S</given-names></name><name><surname>Jerez</surname><given-names>Y</given-names></name><name><surname>Marquez-Rodas</surname><given-names>I</given-names></name><name><surname>Galv&#x000e3;o</surname><given-names>DA</given-names></name><name><surname>Newton</surname><given-names>RU</given-names></name><etal/></person-group><article-title>Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial</article-title><source>Breast Cancer Res Treat</source><year>2015</year><volume>153</volume><issue>2</issue><fpage>371</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1007/s10549-015-3541-x</pub-id><pub-id pub-id-type="pmid">26293147</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Casla S, L&#x000f3;pez-Tarruella S, Jerez Y, Marquez-Rodas I, Galv&#x000e3;o DA, Newton RU et al (2015) Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial. Breast Cancer Res Treat 153(2):371&#x02013;382<pub-id pub-id-type="pmid">26293147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Dieli-Conwright</surname><given-names>CM</given-names></name><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>Demark-Wahnefried</surname><given-names>W</given-names></name><name><surname>Sami</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Sweeney</surname><given-names>FC</given-names></name><etal/></person-group><article-title>Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial 11 Medical and Health Sciences 1117 Public Health and Health Services</article-title><source>Breast Cancer Res</source><year>2018</year><volume>20</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">29291743</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Sweeney FC et al (2018) Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial 11 Medical and Health Sciences 1117 Public Health and Health Services. Breast Cancer Res 20(1):1&#x02013;10<pub-id pub-id-type="pmid">29291743</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">NCT02056067. Hormones and Physical Exercise (HOPE) Study (2014) <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/show/NCT02056067">https://clinicaltrials.gov/show/NCT02056067</ext-link> [Internet] 10(4):654-62. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02024658/full">https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02024658/full</ext-link></mixed-citation></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Duggan</surname><given-names>C</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>CY</given-names></name><name><surname>McTiernan</surname><given-names>A</given-names></name></person-group><article-title>Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2014</year><volume>23</volume><issue>4</issue><fpage>648</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-13-1155</pub-id><pub-id pub-id-type="pmid">24501378</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Duggan C, Xiao L, Wang CY, McTiernan A (2014) Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 23(4):648&#x02013;657<pub-id pub-id-type="pmid">24501378</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>C</given-names></name><name><surname>Kayser</surname><given-names>B</given-names></name></person-group><article-title>Preoperative high-intensity interval training is effective and safe in deconditioned patients with lung cancer: a randomized clinical trial</article-title><source>J Rehabil Med</source><year>2019</year><volume>51</volume><issue>9</issue><fpage>712</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.2340/16501977-2592</pub-id><pub-id pub-id-type="pmid">31468059</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Bhatia C, Kayser B (2019) Preoperative high-intensity interval training is effective and safe in deconditioned patients with lung cancer: a randomized clinical trial. J Rehabil Med 51(9):712&#x02013;718<pub-id pub-id-type="pmid">31468059</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>AM</given-names></name><name><surname>Van Weert</surname><given-names>E</given-names></name><name><surname>Korstjens</surname><given-names>I</given-names></name><name><surname>Hoekstra-Weebers</surname><given-names>JEHM</given-names></name><name><surname>Van Der Schans</surname><given-names>CP</given-names></name><name><surname>Zonderland</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Improved physical fitness of cancer survivors: a randomised controlled trial comparing physical training with physical and cognitive-behavioural training</article-title><source>Acta Oncol (Madr)</source><year>2008</year><volume>47</volume><issue>5</issue><fpage>825</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1080/02841860701666063</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">May AM, Van Weert E, Korstjens I, Hoekstra-Weebers JEHM, Van Der Schans CP, Zonderland ML et al (2008) Improved physical fitness of cancer survivors: a randomised controlled trial comparing physical training with physical and cognitive-behavioural training. Acta Oncol (Madr) 47(5):825&#x02013;834</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Quist</surname><given-names>M</given-names></name><name><surname>Rorth</surname><given-names>M</given-names></name><name><surname>Zacho</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>C</given-names></name><name><surname>Moeller</surname><given-names>T</given-names></name><name><surname>Midtgaard</surname><given-names>J</given-names></name><etal/></person-group><article-title>High-intensity resistance and cardiovascular training improve physical capacity in cancer patients undergoing chemotherapy</article-title><source>Scand J Med Sci Sport</source><year>2006</year><volume>16</volume><issue>5</issue><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0838.2005.00503.x</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Quist M, Rorth M, Zacho M, Andersen C, Moeller T, Midtgaard J et al (2006) High-intensity resistance and cardiovascular training improve physical capacity in cancer patients undergoing chemotherapy. Scand J Med Sci Sport 16(5):349&#x02013;357</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Scott JM, Iyengar NM, Nilsen TS, Thomas SM, Ii JH, Sasso J et&#x000a0;al (2019) HHS Public Access. 124(12):2552-60</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Edvardsen</surname><given-names>E</given-names></name><name><surname>Skj&#x000f8;nsberg</surname><given-names>OH</given-names></name><name><surname>Holme</surname><given-names>I</given-names></name><name><surname>Nordsletten</surname><given-names>L</given-names></name><name><surname>Borchsenius</surname><given-names>F</given-names></name><name><surname>Anderssen</surname><given-names>SA</given-names></name></person-group><article-title>High-intensity training following lung cancer surgery: a randomised controlled trial</article-title><source>Thorax</source><year>2015</year><volume>70</volume><issue>3</issue><fpage>244</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2014-205944</pub-id><pub-id pub-id-type="pmid">25323620</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Edvardsen E, Skj&#x000f8;nsberg OH, Holme I, Nordsletten L, Borchsenius F, Anderssen SA (2015) High-intensity training following lung cancer surgery: a randomised controlled trial. Thorax 70(3):244&#x02013;250<pub-id pub-id-type="pmid">25323620</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Grabenbauer A, Grabenbauer AJ, Lengenfelder R, Grabenbauer GG, Distel L V (2016) Feasibility of a 12-month-exercise intervention during and after radiation and chemotherapy in cancer patients: impact on quality of life, peak oxygen consumption, and body composition. Radiat Oncol [Internet] 11(1):5&#x02013;11. Disponible en: 10.1186/s13014-016-0619-5</mixed-citation></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Courneya</surname><given-names>KS</given-names></name><name><surname>Vardy</surname><given-names>JL</given-names></name><name><surname>O&#x02019;Callaghan</surname><given-names>CJ</given-names></name><name><surname>Friedenreich</surname><given-names>CM</given-names></name><name><surname>Campbell</surname><given-names>KL</given-names></name><name><surname>Prapavessis</surname><given-names>H</given-names></name><etal/></person-group><article-title>Effects of a structured exercise program on physical activity and fitness in colon cancer survivors: one year feasibility results from the CHALLENGE trial</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2016</year><volume>25</volume><issue>6</issue><fpage>969</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-15-1267</pub-id><pub-id pub-id-type="pmid">27197271</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Courneya KS, Vardy JL, O&#x02019;Callaghan CJ, Friedenreich CM, Campbell KL, Prapavessis H et al (2016) Effects of a structured exercise program on physical activity and fitness in colon cancer survivors: one year feasibility results from the CHALLENGE trial. Cancer Epidemiol Biomarkers Prev 25(6):969&#x02013;977<pub-id pub-id-type="pmid">27197271</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>SC</given-names></name><name><surname>DeLorey</surname><given-names>DS</given-names></name><name><surname>Davenport</surname><given-names>MH</given-names></name><name><surname>Stickland</surname><given-names>MK</given-names></name><name><surname>Fairey</surname><given-names>AS</given-names></name><name><surname>North</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial</article-title><source>Cancer</source><year>2017</year><volume>123</volume><issue>20</issue><fpage>4057</fpage><lpage>4065</lpage><pub-id pub-id-type="doi">10.1002/cncr.30859</pub-id><pub-id pub-id-type="pmid">28708930</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Adams SC, DeLorey DS, Davenport MH, Stickland MK, Fairey AS, North S et al (2017) Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer 123(20):4057&#x02013;4065<pub-id pub-id-type="pmid">28708930</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Alizadeh AM, Isanejad A, Sadighi S, Mardani M, kalaghchi B, Hassan ZM (2019) High-intensity interval training can modulate the systemic inflammation and HSP70 in the breast cancer: a randomized control trial. J Cancer Res Clin Oncol [Internet] 145(10):2583&#x02013;93. Disponible en: 10.1007/s00432-019-02996-y</mixed-citation></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Lahart</surname><given-names>IM</given-names></name><name><surname>Carmichael</surname><given-names>AR</given-names></name><name><surname>Nevill</surname><given-names>AM</given-names></name><name><surname>Kitas</surname><given-names>GD</given-names></name><name><surname>Metsios</surname><given-names>GS</given-names></name></person-group><article-title>The effects of a home-based physical activity intervention on cardiorespiratory fitness in breast cancer survivors; a randomised controlled trial</article-title><source>J Sports Sci</source><year>2018</year><volume>36</volume><issue>10</issue><fpage>1077</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1080/02640414.2017.1356025</pub-id><pub-id pub-id-type="pmid">28745131</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Lahart IM, Carmichael AR, Nevill AM, Kitas GD, Metsios GS (2018) The effects of a home-based physical activity intervention on cardiorespiratory fitness in breast cancer survivors; a randomised controlled trial. J Sports Sci 36(10):1077&#x02013;1086<pub-id pub-id-type="pmid">28745131</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Yee J, Davis GM, Hackett D, Beith JM, Wilcken N, Currow D et&#x000a0;al (2019) Physical activity for symptom management in women with metastatic breast cancer: a randomized feasibility trial on physical activity and breast metastases. J Pain Symptom Manage [Internet] 58(6):929&#x02013;39. Disponible en: 10.1016/j.jpainsymman.2019.07.022</mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z</given-names></name></person-group><article-title>Effect of anthracycline combined with aerobic exercise on the treatment of breast cancer</article-title><source>Pak J Pharm Sci</source><year>2018</year><volume>31</volume><issue>3</issue><fpage>1125</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">29735461</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Ma Z (2018) Effect of anthracycline combined with aerobic exercise on the treatment of breast cancer. Pak J Pharm Sci 31(3):1125&#x02013;1129<pub-id pub-id-type="pmid">29735461</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>